Febrile Neutropenia Overview

Save information for later
Sign Up

Learn About Febrile Neutropenia

What is the definition of Febrile Neutropenia?
Febrile neutropenia, also called neutropenic fever, is a condition in which an individual has a fever greater than or equal to 101° F for at least an hour and a low neutrophil count. This is usually due to an infection. Febrile neutropenia commonly occurs as a complication in patients with cancer who are undergoing chemotherapy.
What are the symptoms of Febrile Neutropenia?
Symptoms of febrile neutropenia include a fever greater than or equal to 101° F for at least an hour, a low neutrophil count, and signs and symptoms of an infection such as tenderness or pain.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Febrile Neutropenia?
Treatment for patients with febrile neutropenia depends on their overall condition. Treatments for febrile neutropenia include medications such as fluoroquinolone plus amoxicillin/clavulanate, clindamycin, cefepime, carbapenems, piperacillin, tazobactam, vancomycin, linezolid, daptomycin, polymyxin, colistin, tigecycline, triazole, trimethoprim-sulfamethoxazole, or a nucleoside reverse transcription inhibitor.
Who are the top Febrile Neutropenia Local Doctors?
Elite in Febrile Neutropenia
Dr. Zsolt Szabo
Radiology
Elite in Febrile Neutropenia
Dr. Zsolt Szabo
Radiology

Johns Hopkins Hospital

600 N Wolfe St, 
Baltimore, MD 
410-955-6500
Languages Spoken:
English

Zsolt Szabo is a Radiologist in Baltimore, Maryland. Dr. Szabo is rated as an Elite provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Febrile Neutropenia, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Lung Nodules, and Prostatectomy.

Gary Lyman
Elite in Febrile Neutropenia
Dr. Gary Lyman
Hematology
Elite in Febrile Neutropenia
Dr. Gary Lyman
Hematology

Fred Hutchinson Cancer Center

1100 Fairview Ave N, 
Seattle, WA 
206-667-6670
Languages Spoken:
English
See accepted insurances

Gary Lyman is a Hematologist in Seattle, Washington. Dr. Lyman is rated as an Elite provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Febrile Neutropenia, Agranulocytosis, Venous Thromboembolism (VTE), and Breast Cancer.

 
 
 
 
Learn about our expert tiers
Learn More
Matti S. Aapro
Elite in Febrile Neutropenia
Matti S. Aapro
Elite in Febrile Neutropenia
Matti S. Aapro
Genolier, VD, CH 

Matti Aapro practices in Genolier, Switzerland. Aapro is rated as an Elite expert by MediFind in the treatment of Febrile Neutropenia. Their top areas of expertise are Febrile Neutropenia, Agranulocytosis, Breast Cancer, and HER2 Negative Breast Cancer.

View All Doctors
What are the latest Febrile Neutropenia Clinical Trials?
A Prospective, Single-Arm, Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
A Prospective, Single-Arm, Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
Enrollment Status: Recruiting
Publish Date: February 03, 2026
Intervention Type: Drug
Study Phase: Phase 1

Summary: This is a single-arm pilot clinical trial evaluating dalbavancin-based prophylaxis in children and adolescents with acute myeloid leukemia or relapsed lymphoblastic leukemia receiving myelosuppressive chemotherapy. Primary objective: \- To estimate the rate of bacterial bloodstream infection in pediatric patients with AML or relapsed ALL undergoing chemotherapy receiving dalbavancin-based prophyla...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Appropriate Management of Bacteriemic Febrile Neutropenia in High-Risk Hematological Patients. Relationship Between Duration of Antibiotic Administration, Outcome and Resistance Profile
Appropriate Management of Bacteriemic Febrile Neutropenia in High-Risk Hematological Patients. Relationship Between Duration of Antibiotic Administration, Outcome and Resistance Profile
Enrollment Status: Recruiting
Publish Date: January 28, 2026
Intervention Type: Other
Study Phase: Not Applicable

Summary: The goal of this clinical trial is to learn if a personalized duration of antibiotic therapy, based on clinical stability, is as effective as a standard duration of at least 10 days in hospitalized patients with hematologic malignancies (such as leukemia or lymphoma) who develop febrile neutropenia and Gram-negative bacteraemia. The main questions it aims to answer are: * Can a personalized antibi...

View All Clinical Trials